Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial.

Mathieu, Chantal

Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial. [electronic resource] - Diabetes, obesity & metabolism 05 2018 - 1148-1155 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1463-1326

10.1111/dom.13205 doi


Adult
Blood Glucose--analysis
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1--blood
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Drug Compounding
Drug Monitoring
Drug Therapy, Combination--adverse effects
Female
Follow-Up Studies
Glycated Hemoglobin--analysis
Humans
Hyperglycemia--prevention & control
Hypoglycemia--chemically induced
Hypoglycemic Agents--administration & dosage
Insulin Aspart--administration & dosage
Insulin Detemir--administration & dosage
Male
Meals
Middle Aged